Azole resistance in Aspergillus fumigatus is a One Health resistance threat, where azole fungicide exposure compromises the efficacy of medical azoles. The use of the recently authorized fungicide ipflufenoquin, which shares its mode-of-action with a new antifungal olorofim, underscores the need for risk assessment for dual use of antifungals.
Keywords: Aspergillus fumigatus; DHODH inhibitor; One Health; olorofim; triazole resistance.
Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.